Inventor · disambiguated record
Xueshi Hao
Also filed as: HAO XUESHI
4 granted patents·5 pending applications·10 citations·filing 2009–2022
64Inventor score
Top patents by PatentIndex Score
9 records- 0179US8546370B2Compounds and compositions as kinase inhibitorsOKRAM BARUN·Filed 2009·Granted Oct 1, 2013·9 cites·25 claims
- 0265US9624520B2Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residuesGEIERSTANGER BERNHARD·Filed 2014·Granted Apr 18, 2017·1 cites·7 claims
- 0365US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0454US8785151B2Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residuesGEIERSTANGER BERNHARD·Filed 2009·Granted Jul 22, 2014·0 cites·7 claims
- 0552US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 0652US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0749US2021170043A1Dc-sign antibody conjugates comprising sting agonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0845US2020131474A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0934US2011053897A1Compounds and compositions as syk kinase inhibitorsIRM LLC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →